Navigation Links
Tampa Bay Doctor Agrees to Pay United States $1.7 Million to Resolve Medicare Fraud Allegations
Date:7/17/2009

WASHINGTON, July 17 /PRNewswire-USNewswire/ -- Dr. Gabriel DeCandido, a physician practicing internal medicine in Largo, Fla., has agreed to pay the United States $1.7 million to settle allegations that he defrauded the Medicare program, the Department of Justice announced today.

In a complaint filed in the United States District Court for the Middle District of Florida, United States ex rel. Michael Flanery v. Dr. Gabriel DeCandido, et al., the United States alleged that Dr. DeCandido violated the False Claims Act by billing the Medicare program for higher levels of service than he actually rendered to patients and by billing for services not provided.

"Every year, billions of dollars are lost to Medicare and Medicaid fraud," said Tony West, Assistant Attorney of the Justice Department's Civil Division. "This case demonstrates our commitment to vigorously pursuing those who defraud Medicare. Taxpayer dollars should be spent on health care services for patients, not wasted on fraud and abuse."

The court found that the United States presented sufficient evidence showing that Dr. DeCandido attempted to hide and transfer his assets to avoid having to pay a judgment to the United States. To ensure that any judgment against Dr. DeCandido would be satisfied, the court permitted the government to seize five of his vehicles and garnish $976,000 that Dr. DeCandido transferred to his wife.

Today's settlement also resolves allegations made by a relator, commonly known as a "whistleblower," under the False Claims Act, which allows a qualifying relator to receive a share of the settlement proceeds. The relator's suit was filed in the United States District Court for the Middle District of Florida. The relator's share of the recovery is $306,000.

As part of today's agreement, Dr. DeCandido entered into a Corporate Integrity Agreement (CIA) with the United States Department of Health and Human Services, Office of Inspector General, requiring him to engage in significant compliance efforts over the next five years. Among other provisions, the CIA requires Dr. DeCandido to engage independent review organizations to review the accuracy of the claims that he submits to the Medicare program.

Assistant Attorney West acknowledged the contributions made by both the Commercial Litigation Branch of the Civil Division and the Office of Counsel to the Inspector General for the Department of Health and Human Services in investigating and resolving this matter.


'/>"/>
SOURCE U.S. Department of Justice
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Vein & Cosmetic Center of Tampa Bay Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler
2. The National Council on Aging and CVS/pharmacy Educate Tampa Seniors on Medication Management and How to Save Money on Prescription Drugs
3. Tampa Disinfection Company Booming After Swine Flu Scare
4. Chief Technology Officer for Baxa Corporations Subsidiary, FHT, Inc., Presents at the Fourth Annual unSUMMIT for Bedside Barcoding in Tampa, Florida
5. eMed-ID, Worlds First Medical Identification Franchise, Opens Tampa Bay Market for Franchise Sales
6. Highlights of Economic and Business Growth in the Tampa Bay Region (News Briefs)
7. Tampa Bay Becomes First Community to Jump-Start Americas E-Health Revolution
8. Tampa Bay Veterinarian Featured in People Magazine's Heroes in Hard Times
9. 100 NFL Legends Coming Together in Tampa During Super Bowl Week to Raise Awareness and Funds for Retired Players in Crisis
10. Tampa is Latest Recipient of Project Lifesaver Grant Funds Through The National Autism Association
11. Highlights of Economic and Business Growth in the Tampa Bay Region
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2017)... ... February 26, 2017 , ... IndustryArchive.Org . is announcing a ... Marketing. B2B Sellers will now only pay for B.A.N.T. quality sales leads based on ... IndustryArchive.Org, said, “Given the new reality that B2B buyers are controlling the sales process ...
(Date:2/26/2017)... , ... February 26, 2017 , ... ODH, Inc.™ ... Summit, February 27-28 at the Sheraton Pentagon City Hotel in Arlington, VA. ODH’s director ... to use behavioral health analytics to improve Medicaid population health management. , ODH will ...
(Date:2/26/2017)... ... February 26, 2017 , ... Occupational pesticide exposure ... a specific LRRK2 mutation, according to a study released today at the 1st ... of a link between pesticides and incidence of sporadic PD through occupational exposure. ...
(Date:2/24/2017)... ... 24, 2017 , ... HealthPostures, expert standing desk solution designer, ... built into the home office sit stand solution are bold colors, a new ... the benefits embedded in the TaskMate Go are available 24/7 through HealthPostures' online ...
(Date:2/24/2017)... ... 24, 2017 , ... Only two months after the official release of The ... Cannes (France), XO Private has initiated a second print-run of its lavish luxury travel ... metre across when open, weighs in at more than six kilos, retails at EUR ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... Feb. 27, 2017  A landmark study ... , MBBS, PhD, FRACS, of  Sydney Heart and ... Sydney will be published in the February 28, ... American College of Cardiology . According to the study, which ... bypass surgery technique (anOPCABG) reduced postoperative stroke ...
(Date:2/27/2017)...  International Biophysics Corporation, a global medical device manufacturer based ... 34% revenue growth in 2016 when compared to the previous ... growth was fueled by its AffloVest® sales in ... of its global sales of surgical product lines. ... enter our 25 th year in delivering high-quality, innovative ...
(Date:2/27/2017)... ROCKVILLE, Md. , Feb. 27, 2017 /PRNewswire/ ... "RegeneRx"), a clinical-stage drug development company focused on ... its licensee for RGN-137, GtreeBNT Co., Ltd., received ... its Phase 3 clinical trial design for RGN-137 ... dermal wound healing gel that incorporates Thymosin beta ...
Breaking Medicine Technology: